WE in ves tigate d th e effect of ferulic acid (FA) and is oferulic acid (IFA),
Introduction
Respiratory syncytial virus (RSV) is the major c ause of acute low e r respiratory tract illne sses such as bronchiolitis and pneumonia in infants and young childre n, and can c ause se ve re, e ve n fatal, infec tions in the e lderly. 1 Seve ral studies have indicate d that RSV is release d initially from upper resp iratory tract infe ctions and then re aches the bronchoalveolar region, w here viruses induce inflammation of the airw ay epithe lium ac companied by pe ribronchiolar infiltrations of neutrophils. 1, 2 It is w ell know n that neutrophil ac cumulation is an important charac te ristic of inflammation and modulate s various inflammatory reactions . 3 Sinc e the initial disc overy of interle ukin-8 as a nove l neutrophil chemotactic c ytokine , 4 -6 it has sinc e bee n named a chemokine and bee n found in the conditioned medium (CM) of various c ells in response to stimulation w ith lipopolysac charide (LPS) as w ell as se ve ral virus infe ctions. We previously reporte d that RSV infe ction strongly induc es the production of macrophage inflammatory protein-2 (MIP-2), a murine counterpart of che mokine family, 7 in RAW 264.7 cells. 8 ,9 On the othe r hand, the rhizoma of Cim icifug a sp., such as Cim icifu ga h e ra c le ifo lia (CH) Komarov and Cim icifu ga da h u rica Max im are used frequently as antip yre tic, analge sic and anti-inflammatory drugs in Japanese traditional me dic ine. Fe rulic acid (FA), 3-(4-hydrox y-3-me thox yphenyl)-2-propenic ac id and its is omer isoferulic acid (IFA), 3-(3-hydrox y-4-me thox yphenyl)-2-propenic, have bee n re ce ntly rec ognized as the main active components of CH ex tract in the inflammation model in rats. 10 In the light of these findings, w e ex amine d w he the r FA and IFA show inhibitory effects on MIP-2 production in response to RSV infe ction. 
Materials and methods

Preparation of drugs
Statistical analysis
The results w e re ex pressed as mean± standard deviation (SD). The diffe renc es w ere ex amined by Bonferroni's least-significant differe nce test.
Results and discussion
In the control c ulture , MIP-2 le ve ls in the CM inc re ased to the le ve l of 20.4± 0.8 ng/ml until 20 h after infe ction in a time -de pendent manner. In the uninfec te d c ells, no significant produc tion (less than 0.5 ng/ml) w as observe d throughout the ex perime nts (data not show n). When the infected c ells w ere c ulture d in the presenc e of FA and IFA, the se drugs show ed inhibitory effe cts on MIP-2 production in a dose-dep endent manne r. At 20 h, FA reduced MIP-2 levels to 74.4 and 42.8% of c ontrol at doses of 50 and 500 m M, respe ctive ly (Fig. 1) . In addition, IFA also re duce d MIP-2 levels to 61.8, 58.0 and 35.6% of c ontrol at doses of 5, 50 and 500 m M, respective ly (Fig. 2 ). These value s w ere significantly S. Sa k a i e t al. How e ver, the me chanisms of anti-inflammatory effect of FA and IFA are not unde rstood c omple te ly. In addition to a previous report indicating that FA inhibits MIP-2 production in resp onse to LPS stimulation in RAW264.7 ce lls, 1 2 this study confirmed that both FA and IFA inhibit MIP-2 produc tion even in response to RSV infec tion in RAW264.7 c ells in a dose-depende nt manner. Since peribronchiolar infiltrations of ne utrophils are important pathoge nesis in RSV infec tions, 1 3,1 4 MIP-2-inducing activity of RSV should play a ke y role. Taking into acc ount the fac t that neutrophils c an cause tissue injurie s, such as lung damage in adult resp iratory distre ss syndrome and other inflammatory disease s, through the p roduc tion of supe rox ide or some enzymes, in addition to killing inge ste d or invading mic robe s, 15 -1 7 these data sugge st that FA and IFA might contribute at least in part to the anti-inflammatory drug e ffec t of CH ex tract through the reduction of MIP-2 levels, and the reby the reduction of neutrophil infiltratio n into the inflammatory site s. In addition, the use of FA and IFA or CH ex tract seems to be a novel and attractive strate gy for control of pneumonia induce d by ce rtain virus infe ctions, including RSV infe c tion.
